Physician profile
Ken Smith
NPI 1033101126
$3,361.61
in general payments reported to CMS, 2019-2025
31 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,674 · 2020: $888 · 2021: $314 · 2022: $178 · 2023: $88.70 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $911.93 | 2020-2025 | Omnia, Excelsiusgps Robotic Navigation System |
| Medical Device Business Services, INC. | $713.86 | 2019 | |
| Depuy Synthes Sales INC. | $466.07 | 2019-2022 | |
| Medtronic USA, INC. | $215.78 | 2019-2020 | |
| Intrinsic Therapeutics | $153.66 | 2020-2021 | |
| Providence Medical Technology, INC. | $86.20 | 2019 | |
| Nevro Corp. | $81.30 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $69.79 | 2019-2020 | |
| Esperion Therapeutics, INC. | $62.69 | 2021-2022 | |
| Abbvie INC. | $54.20 | 2021 | |
| Chiesi USA, INC. | $53.90 | 2019-2021 | |
| Life Spine, INC. | $53.43 | 2019 | |
| Csl Behring | $51.87 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $45.43 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.94 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $29.88 | 2019 | |
| Cerapedics INC. | $27.21 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Axogen | $26.53 | 2019 | |
| Integra Lifesciences Corporation | $24.92 | 2019-2021 | |
| Ucb, INC. | $23.86 | 2023 | Briviact |
| Nuvasive, INC. | $23.46 | 2020 | |
| Paratek Pharmaceuticals, INC. | $19.66 | 2022 | |
| Kci USA, INC. | $19.29 | 2021 | |
| Xeris Pharmaceuticals, INC. | $18.98 | 2022 | |
| Medtronic, INC. | $18.66 | 2023 | Catalyft Pl Expandable Interbody System |
| Novo Nordisk INC | $16.23 | 2022 | |
| Misonix INC | $14.95 | 2021 | |
| Pfizer INC. | $13.46 | 2022 | |
| Si-Bone, INC. | $13.44 | 2020 | |
| Augmedics INC. | $11.23 | 2021 | |
| Nalu Medical, INC. | $8.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.